In 2020 the FDA approved Sogroya (somapacitan-beco) a human growth hormone analog indicated for the replacement of endogenous growth hormone in adults with growth hormone deficiency
Patients also exploring comparisons may find reassurance in this guide on switching from Mounjaro to Wegovy, which highlights the importance of supervised transitions
Many of the effects of DPP-4 inhibitors in large-scale clinical trials, including their effects on atherosclerotic ischemic events, heart failure, sodium excretion, albuminuria and glomerular function may be meaningfully influenced by their actions to enhance of the endogenous stem-cell chemokine, SDF-1
p=0,004) 150
Gastrointestinal bleeding, ulcer disease, and hemorrhagic stroke remain clinically significant risks, particularly in older adults
Metabolic Powerhouses: GLP-1 RAs and SGLT2 Inhibitors GLP-1 Receptor Agonists (GLP-1 RA) The Brain-Gut Connection Mechanism: Mimics the natural incretin hormone GLP-1 to regulate metabolism and appetite